Pharmaceutical

Lupin receives USFDA approval for Pitolisant Tablets

The approval covers Pitolisant Tablets 4.45 mg and 17.8 mg, bioequivalent to Wa...

USFDA classifies Aurobindo Pharma’s Raleigh plant as VAI

The facility received 11 observations during the USFDA inspection conducted fro...

CDSCO directs action against unapproved Enclomiphene dr...

State and UT Drugs Controllers asked to identify manufacturers, marketers, dist...

LSSSDC to organise Skillverse 2026 National Skill Summi...

LSSSDC Skillverse 2026 will focus on workforce requirements, Industry 5.0, Glob...

BMS secures FDA accelerated approval for Zenbexus in mu...

The combination is intended for patients who have previously received at least o...

Xanadu and University of Alberta to develop quantum alg...

The collaboration aims to develop new quantum algorithms that could accelerate t...

Gulfstream Intelligence launches regulatory intelligenc...

Platform brings regulatory intelligence, labelling, gap assessments, health aut...

Why India’s medicines need integrated authentication, e...

Triggered by recent high profile operations involving counterfeit semaglutide i...

Akeso secures China NMPA authorisation for ivonescimab ...

The decision marks the third NMPA-approved indication for an ivonescimab-contain...

Remepy secures $36m funding for hybrid drug pipeline ex...

The proceeds will also be used to fund Remepy’s lead product Hybridopa’s global ...

BASF introduces Floragenist floral active ingredients f...

BASF’s Personal Care business introduces Floragenist Rose and Floragenist Bloss...

BIRAC showcases biotech and medtech start-ups at Bharat...

BIRAC’s pavilion features start-ups working on medical devices, rehabilitation ...

Back to basics: Metal detection in pharmaceutical manuf...

Stuart Preston explains how metal detection supports contamination control, pro...

Alfasigma signs agreement to acquire Nordic Group

The transaction is structured through a share purchase agreement with SEVER Life...

Mereo BioPharma and Sentynl Therapeutics sign licensing...

The arrangement enables Sentynl to acquire exclusive US commercial rights to alv...

India’s pharma exports rise 6.8% to $8.1 billion in Q1 ...

Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surg...